XML 58 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
12 Months Ended
Feb. 09, 2022
Dec. 31, 2023
Dec. 31, 2022
Feb. 07, 2024
Dec. 18, 2023
Jul. 28, 2023
Feb. 09, 2023
Subsidiary, Sale of Stock [Line Items]              
Proceeds from issuance of common stock   $ 202,000,000        
Deferred underwriting commissions   $ 7,070,000 $ 7,070,000        
Common Class A [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares subject to redemption   5,307,292 20,200,000   4,815,153 5,307,292 5,670,123
Common Class A [Member] | Subsequent Event [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares subject to redemption       4,815,153      
Underwriting Agreement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Deferred underwriting fees   $ 2,525,000          
Deferred underwriting commission per unit   $ 0.35          
Deferred underwriting commissions   $ 7,070,000          
Underwriting Agreement [Member] | Sponsor [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares issued, shares, share-based payment arrangement, forfeited   700,000          
Over-Allotment Option [Member] | Common Class A [Member]              
Subsidiary, Sale of Stock [Line Items]              
Maxim IPO shares issued 200,000            
Over-Allotment Option [Member] | Underwriting Agreement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Over allotment option period   45 days          
Maxim IPO shares issued   3,000,000          
Proceeds from issuance of common stock   $ 2,000,000          
IPO [Member]              
Subsidiary, Sale of Stock [Line Items]              
Maxim IPO shares issued   303,000          
Deferred underwriting fees $ 7,070,000            
IPO [Member] | Common Class A [Member]              
Subsidiary, Sale of Stock [Line Items]              
Maxim IPO shares issued 20,200,000